To compare the number of circulating EPCs and plasma levels of VEGF and SDF-1α among LC patients with (n = 66) or without HCC (n =12) and the healthy control (n = 25) subjects, subgroup analysis was performed (Figure 1A). This evidence concerns the gene CXCL12 and hepatocellular carcinoma.